Fingerprint
Dive into the research topics of 'Success of short-term, higher-dose imatinib mesylate to induce clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically